Skip to content
Sexuality – Lifestyle
Author:
AbbVie
AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
June 8, 2026
AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
June 2, 2026
AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
May 29, 2026